Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-05

Clinical Trial Update: Predictive Value of Maternal Blood Protein Signatures in Preterm Birth

View source ↗

Summary

A completed clinical trial evaluating whether maternal blood protein signatures can predict preterm birth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: HBI Solutions Inc. | Conditions: Preterm Birth | Status: COMPLETED